Wells Fargo
PPH icon

Wells Fargo’s VanEck Pharmaceutical ETF PPH Stock Holding History

Wells Fargo’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,200
Closed -$721K – 7324
2025
Q2 		$721K Buy
+8,200
New +$711K ﹤0.01% 3905

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Wells Fargo's PPH Position: Q2 2026 in Review

Wells Fargo reduced its VanEck Pharmaceutical ETF (PPH) stake by 39% in Q2 2026, selling an estimated $17.5K and leaving 262 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5840.

Wells Fargo first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.6M in Q4 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Wells Fargo held 262 shares of VanEck Pharmaceutical ETF worth $28.7K as of Q2 2026.
  • Wells Fargo sold 169 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $17.5K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5840 holding.
  • Wells Fargo first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's VanEck Pharmaceutical ETF position peaked at $51.6M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.